Testing effectiveness (Phase 2)UnknownNCT04793568
What this trial is testing
Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study
Who this might be right for
Critically Ill Patients
Nantes University Hospital 109